ES475178A1 - Un metodo mejorado para producir antibiotico c-15003 p-3. - Google Patents

Un metodo mejorado para producir antibiotico c-15003 p-3.

Info

Publication number
ES475178A1
ES475178A1 ES78475178A ES475178A ES475178A1 ES 475178 A1 ES475178 A1 ES 475178A1 ES 78475178 A ES78475178 A ES 78475178A ES 475178 A ES475178 A ES 475178A ES 475178 A1 ES475178 A1 ES 475178A1
Authority
ES
Spain
Prior art keywords
antibiotic
producing antibiotic
antiprotozoan
antifungal
cultivating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES78475178A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES475178A1 publication Critical patent/ES475178A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365Nocardia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/872Nocardia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un método mejorado para producir antibiótico C-15003 p-3 cultivando un microorganismo que pertenece al genero Nocardia y que es capaz de producir el antibiótico C-15003 p-3 en un medio de cultivo que contiene fuentes de carbono asimilable y fuentes de nitrógeno digestible, que comprende incorporar valina, ácido isobutirico y/o sus derivados, como substancias aditivas, al medio de cultivo.
ES78475178A 1977-11-18 1978-11-17 Un metodo mejorado para producir antibiotico c-15003 p-3. Expired ES475178A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52139385A JPS6016236B2 (ja) 1977-11-18 1977-11-18 抗生物質c―15003 p―3の製造法

Publications (1)

Publication Number Publication Date
ES475178A1 true ES475178A1 (es) 1979-05-16

Family

ID=15244070

Family Applications (1)

Application Number Title Priority Date Filing Date
ES78475178A Expired ES475178A1 (es) 1977-11-18 1978-11-17 Un metodo mejorado para producir antibiotico c-15003 p-3.

Country Status (13)

Country Link
US (1) US4228239A (es)
JP (1) JPS6016236B2 (es)
CH (1) CH640270A5 (es)
DE (1) DE2849696A1 (es)
DK (1) DK144657C (es)
ES (1) ES475178A1 (es)
FR (1) FR2409307A1 (es)
GB (1) GB2011385B (es)
HU (1) HU179600B (es)
IT (1) IT1206651B (es)
NL (1) NL7811325A (es)
PL (1) PL122463B1 (es)
SU (1) SU1036251A3 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4162940A (en) * 1977-03-31 1979-07-31 Takeda Chemical Industries, Ltd. Method for producing Antibiotic C-15003 by culturing nocardia
JPS55162791A (en) * 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS5645483A (en) * 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
JPS56102793A (en) * 1979-12-28 1981-08-17 Takeda Chem Ind Ltd Preparation of antibiotic c-15003 p-3
US6573074B2 (en) * 2000-04-12 2003-06-03 Smithkline Beecham Plc Methods for ansamitocin production
US20110313230A1 (en) 2001-05-11 2011-12-22 Terrance Grant Johns Specific binding proteins and uses thereof
US6790954B2 (en) * 2002-01-29 2004-09-14 Immunogen, Inc. Mutant Actinosynnema pretiosum strain with increased maytansinoid production
EP1627069A4 (en) * 2002-08-08 2010-06-02 Glaxosmithkline Llc PROCESS FOR THE ISOLATION AND PURIFICATION OF ANSAMITOCINES
US7432088B2 (en) 2003-05-08 2008-10-07 Immunogen Inc. Methods for the production of ansamitocins
WO2007067698A2 (en) * 2005-12-08 2007-06-14 Millennium Pharmaceuticals, Inc. Isolation of ansamitocins
US20110076232A1 (en) 2009-09-29 2011-03-31 Ludwig Institute For Cancer Research Specific binding proteins and uses thereof
CN101921817A (zh) * 2010-09-07 2010-12-22 上海交通大学 安莎霉素发酵产量提高方法
DK2836485T3 (en) * 2012-03-17 2018-04-23 Polyphor Ag CONFORMITY LIMITED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3902968A (en) * 1974-04-25 1975-09-02 Merck & Co Inc Fermentation process
JPS58876B2 (ja) * 1975-11-19 1983-01-08 藤沢薬品工業株式会社 Fr −1923 ブツシツノ セイゾウホウホウ
US4151042A (en) * 1977-03-31 1979-04-24 Takeda Chemical Industries, Ltd. Method for producing maytansinol and its derivatives
JPS6010718B2 (ja) * 1977-03-31 1985-03-19 武田薬品工業株式会社 メイタンシノ−ル,メイタナシンおよびメイタンシノ−ル・プロピオネ−トの製造法
FR2385714A1 (fr) * 1977-03-31 1978-10-27 Takeda Chemical Industries Ltd Nouvel antibiotique denomme c-15003, son procede de preparation et son application comme medicament
US4162940A (en) * 1977-03-31 1979-07-31 Takeda Chemical Industries, Ltd. Method for producing Antibiotic C-15003 by culturing nocardia

Also Published As

Publication number Publication date
IT1206651B (it) 1989-04-27
PL211028A1 (pl) 1979-07-16
IT7829922A0 (it) 1978-11-17
DE2849696A1 (de) 1979-05-23
DK514378A (da) 1979-05-19
PL122463B1 (en) 1982-07-31
GB2011385A (en) 1979-07-11
CH640270A5 (de) 1983-12-30
JPS6016236B2 (ja) 1985-04-24
SU1036251A3 (ru) 1983-08-15
US4228239A (en) 1980-10-14
FR2409307A1 (fr) 1979-06-15
NL7811325A (nl) 1979-05-22
DK144657C (da) 1982-11-22
DK144657B (da) 1982-05-03
GB2011385B (en) 1982-05-26
HU179600B (en) 1982-11-29
JPS5473194A (en) 1979-06-12
FR2409307B1 (es) 1981-03-06

Similar Documents

Publication Publication Date Title
DE3067380D1 (en) Enzyme inhibitor produced by cultivation of a streptomyces microorganism, a process for producing it and a culture of the microorganism
UA19162A (uk) Спосіб одержаhhя аhтибіотика s541, штами стрептоміцетів - продуцеhти аhтибіотика s541
ES466791A1 (es) Procedimiento para la produccion de esterastina.
ES475178A1 (es) Un metodo mejorado para producir antibiotico c-15003 p-3.
AU565019B2 (en) Cl-1557 antibiotic/antitumor compounds
DE3066026D1 (en) A method for the production of antibiotic c-15003 p-3
GB1454735A (en) Lincomycin production
ES475179A1 (es) Un metodo mejorado para producir antibiotico c-15003 p-4.
ES463206A1 (es) Un metodo para preparar maytansinol, maytanacina o propiona-to de maytansinol.
ES8302097A1 (es) Un metodo para producir enduracidina
ES432549A1 (es) Un procedimiento para la produccion de desacetoxicefalospo- rina c.
ES472318A1 (es) Un metodo para preparar el antibiotico c-14482 a.
ES382658A1 (es) Procedimiento de produccion de un nuevo antibiotico.
JPS5231001A (en) Novel antibiotics-complex
GB1518633A (en) Glycopeptide
IE46064L (en) Antibiotic c-15003
ES472790A1 (es) Un procedimiento para obtener un nuevo antibiotico antitumo-ral la auromomicina
AU2432488A (en) Microbiological process for making uk-61, 689 and microorganisms useful therefor
ZA763893B (en) Method for the culture of monocellular microorganisms and microorganism obtained thereby
GB1387511A (en) Method for the preparation of hydrogen peroxide
DE3169901D1 (en) Antibiotic am-5344-a2 and process for the preparation thereof
IE39682B1 (en) An improvement in the production of rifamycin b
ES419574A1 (es) Procedimiento para la produccion de agentes antibacteria- nos.
GB1252792A (es)
JPS53133689A (en) Preparation of pyoluteorin and related compounds

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971201